Clinical trial
Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for…
NCT00020605 · Dana-Farber Cancer Institute, Other · Unknown status
Key facts
| NCT number | NCT00020605 |
|---|---|
| Title | Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-controlled, Phase IIB Study of Oral Naloxone for the Treatment of Opioid-Induced Constipation in Patients With Chronic, Non-malignant Pain or Malignant Pain |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Constipation, Impaction, and Bowel Obstruction, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | naloxone hydrochloride |
| Start date | May 1, 2000 |
| First posted | Apr 5, 2004 |
| Last update posted | Dec 13, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: